{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/08/28/3352586/0/en/quoin-pharmaceuticals-reports-positive-interim-data-from-ongoing-phase-2-3-study-of-qrx003-in-netherton-syndrome.html", "message": "News view counter 906820 successfully enlarged"}